Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Unilife, Novartis Enter Clinical Supply Pact | Contract Pharma

What are you searching for?

Sign in
Breaking News

Unilife, Novartis Enter Clinical Supply Pact

To supply customized injectable delivery device for Novartis target

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Unilife Corp. has entered an agreement with Novartis to supply clinical products from one of its platforms of injectable drug delivery systems for use with an undisclosed, early-stage drug target. Unilife has also granted Novartis an option for exclusivity. Additional terms of the agreement were not disclosed.
 
Unilife will supply a customized delivery device, consisting of syringe, needle, tubing, controller and pump, for the administration of an investigational Novartis drug into a targeted organ in clinical trials. 
 
Alan Shortall, chief executive officer of Unilife, said, “I am pleased with our success to date in being an effective collaborator with Novartis. This is another example of Unilife addressing the unmet needs of pharmaceutical companies to deliver advanced drugs in their pipelines. I am excited to supply Novartis with a differentiated game-changing device that provides alternative options for drug delivery.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics